Relationship between elevation of glycated albumin to glycated hemoglobin ratio in patients with a high bleeding risk of esophageal varices

Hepato-Gastroenterology

Volumn 59, Issue 119, 2012, Pages 2280-2284

  Sakai, Yoshiyuki ^a   Enomoto, Hirayuki ^a   Aizawa, Nobuhiro ^a   Iwata, Yoshinori ^a   Tanaka, Hironori ^a   Ikeda, Naoto ^a   Takashima, Tomoyuki ^a   Takata, Ryo ^a   Iwai, Takashi ^a   Iwata, Kazunari ^a   Saito, Masaki ^a   Imanishi, Hiroyasu ^a   Iijima, Hiroko ^a   Nakamura, Hideji ^a,b   Nishiguchi, Shuhei ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b NISSAY HOSPITAL   (Japan)

Author keywords

Esophageal varices; Glycated albumin; Glycated hemoglobin; Liver cirrhosis; Portal hypertension

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD PUGH SCORE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; ESOPHAGUS VARICES BLEEDING; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HIGH RISK PATIENT; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK ASSESSMENT; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84872086073     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12064     Document Type: Article

References (39)

1. De Franchis R: Evolving consensus in portal hypertension report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43:167-176.
2. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W: Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46:922-938.
3. Garcia-Tsao G, Joseph L: Management and treatment of patients with cirrhosis and portal hypertension: Recommendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program. Am J Gastroenterol 2009; 104:1802-1829.
4. North-Italian Endoscopic Club for the study and treatment of esophageal varices: Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988; 319:983-989.
5. Pilette C, Oberti F, Aubé C, et al.: Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol 1999; 31:867-873.
6. Schepis F, Cammà C, Niceforo D, et al.: Which patients should undergo endoscopic screening for oesophageal varices detection? Hepatology 2001; 33:333-338.
7. Burton JR, Liangpunsakul S, Lapidus J, Giannini E, Chalasani N, Zaman A: Validation of a multivariate model predicting presence and size of varices. J Clin Gastreoenterol 2007; 41:609-615.
8. de Franchis R: Non-invasive (and minimally invasive, diagnosis of esophageal varices. J Hepatol 2008; 49:520-527.
9. Koenig RJ, Peterson CM, Jones RL, et al.: Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 1976; 295:417-420.
10. Bunn HF, Gabbay KH, Gallop PM: The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978; 20:21-27.
11. Tahara Y, Shima K: Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995; 18:440-447.
12. Dolhofer R, Wieland OH: Glycosylation of serum albumin: Elevated glycosyl-albumin in diabetic patients. FEBS Lett 1979; 103:282-286.
13. Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW: Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 1979; 76:4258-4261.
14. Koga M, Kasayama S: Clinical impact of glycated albumin as another glycemic control marker. Endocrine J 2010; 57:751-762.
15. Bando Y, Kanehara H, Toya D, Tanaka N, Kasayama S, Koga M: Association of serum glycated albumin to glycated hemoglobin A1c ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem 2009; 46:368-372.
16. Aizawa N, Enomoto H, Imanishi H, et al.: Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of HCV-related liver fibrosis. World J Hepatol 2012; 4(1):11-17.
17. Paquet KJ: Prophylactic endoscopic sclerosing treatment of esophageal wall in varices: a prospective controlled trial. Endoscopy 1982; 14:4-5.
18. The French METAVIR Cooperative Study Group: Intra-observer and inter-observer variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20:15-20.
19. Madhotra R, Mulcahy HE, Willner I, Reuben A: Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 2002; 34:81-85.
20. Zein CO, Lindor KD, Angulo P: Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. Hepatology 2004; 39:204-210.
21. Giannini E, Botta F, Borro P, et al.: Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of ooesophagealvarices in patients with liver cirrhosis. Gut 2003; 52:1200-1205.
22. Giannini EG, Zaman A, Kreil A, et al.: Platelet count/spleen diameter ratio for the non invasive diagnosis of oesophageal varices. Results of a multicenter, prospective, validation study. Am J Gastroenterol 2006; 101:2511-2519.
23. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T: Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357:1069-1075.
24. Thabut D, Trabut JB, Massard J, et al.: Non-invasive diagnosis of large esophageal varices by fibro-test in patients with cirrhosis: a preliminary retrospective study. Liver Int 2006; 26:271278.
25. Sandrin L, Fourquet B, Hasquenoph JM, et al.: Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29:1705-1713.
26. Bureau C, Metivier S, Peron JM, et al.: Transient elastography accurately predicts presence of clinically significant portal hypertension in patient with chronic liver disease. Aliment Pharmacol Ther 2008; 27:1261-1268.
27. Vizzutti F, Arena U, Romanelli RG, et al.: Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45:1290-1297.
28. Kazemi F, Kettaneh A, N'kontchou G, et al.: Liver stiffness measurement selects patients with cirrhosis at risk of bearing large esophageal varices. J Hepatol 2006; 45:230-235.
29. Rang HK, Jeong YY, Choi JH, et al.: Three-dimensional multidetector row CT portal venography in the evaluation of portosystemic collateral vessels in liver cirrhosis. Radiographics 2002; 22:1053-1061.
30. Kim YJ, Raman SS, Yu NC, To'o KJ, Jutabha R, Lu DS: Esophageal varices in cirrhotic patients: evaluation with liver CT. Am J Roentgenol 2007; 188:139-144.
31. Kim SH, Kim YJ, Lee JM, et al.: Esophageal varices in patients with cirrhosis: multi-detector CT esophagography - comparison with endoscopy. Radiology 2007; 242:759-768.
32. Perri RE, Chiorean MV, Fidler JL, et al.: A prospective evaluation of computerized tomographic (CT scanning as a screening modality for esophageal varices. Hepatology 2008; 47:1587-1594.
33. Eisen GM, Eliakim R, Zaman A, et al.: The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices: a prospective three center pilot study. Endoscopy 2006; 38:31-35.
34. Lapalus MG, Dumortier J, Fumex F, et al.: Esophageal capsule endoscopy versus esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance. Endoscopy 2006; 38:36-41.
35. Pena LR, Cox T, Koch AG, Bosch A: Study comparing esophageal capsule endoscopy versus EGD in the detection of varices. Dig Liver Dis 2008; 40:216-223.
36. De Franchis R, Eisen GM, Laine L, et al.: Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology 2008; 47:1595-1603.
37. Lapalus MG, Ben Soussan E, Gaudric M, et al.: Esophageal capsule endoscopy vs. EGD for the evaluation of portal hypertension: a French prospective multi-center comparative study. Am J Gastroenterol 2009; 104:1112-1118.
38. Zhang C, Thabut D, Kamath PS, Shah VH: Esophageal varices in cirrhotic patients: from variceal screening to primary prophylaxis of the first esophageal variceal bleeding. Liver Int 2010; 31:108-119.
39. Bosch J: Prediction from a hard liver. J Hepatol 2006; 45:174-177.